| Analysis | Metabolite Name | Measured Value | Units | GROUP_ID |
|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | pyridoxamine | 0.4553 | Relative Abundance | CON |
| Reversed phase POSITIVE ION MODE | pyridoxamine | 0.6019 | Relative Abundance | CON |
| Reversed phase POSITIVE ION MODE | pyridoxamine | 0.6154 | Relative Abundance | GOS |
| Reversed phase POSITIVE ION MODE | pyridoxamine | 0.7585 | Relative Abundance | GOS |
| Reversed phase POSITIVE ION MODE | pyridoxamine | 0.7994 | Relative Abundance | GOS |
| Reversed phase POSITIVE ION MODE | pyridoxamine | 0.9499 | Relative Abundance | GOS |
| Reversed phase POSITIVE ION MODE | pyridoxamine | 1.0501 | Relative Abundance | CON |
| Reversed phase POSITIVE ION MODE | pyridoxamine | 1.1973 | Relative Abundance | CON |
| Reversed phase POSITIVE ION MODE | pyridoxamine | 1.1998 | Relative Abundance | CON |
| Reversed phase POSITIVE ION MODE | pyridoxamine | 1.3192 | Relative Abundance | CON |
| Reversed phase POSITIVE ION MODE | pyridoxamine | 1.3549 | Relative Abundance | GOS |
| Reversed phase POSITIVE ION MODE | pyridoxamine | 1.566 | Relative Abundance | GOS |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|